Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 2
Submit an article Journal homepage
146
Views
3
CrossRef citations to date
0
Altmetric
Letter to the Editor

Subacute inflammatory demyelinating polyradiculoneuropathy complicating relapsing Hodgkin lymphoma: another immune-related adverse event of the anti-PD1 therapy?

Andrea Barpa Département de Neurophysiologie, Hôpital de la Pitié-Salpêtrière, APHP, Paris, France; Correspondence[email protected]
,
Laurent Gilardinb Service d’Onco-Hématologie, Hôpital Saint-Louis, APHP, Paris, France; ;c Institut National de la Santé et de la Recherche Médicale (INSERM), Unité Mixte de Recherche en Santé (UMR S) 1138, Centre de Recherche des Cordeliers, Equipe Immunopathology and Therapeutic Immunointervention, Paris, France;
,
Vadim Afanasievd Centre d’Evaluation et Traitement des Neuropathies, Hôpital de la Pitié-Salpêtrière, APHP, Paris, France;
,
Cécile Delormea Département de Neurophysiologie, Hôpital de la Pitié-Salpêtrière, APHP, Paris, France; ;d Centre d’Evaluation et Traitement des Neuropathies, Hôpital de la Pitié-Salpêtrière, APHP, Paris, France;
,
Karine Vialaa Département de Neurophysiologie, Hôpital de la Pitié-Salpêtrière, APHP, Paris, France; ;d Centre d’Evaluation et Traitement des Neuropathies, Hôpital de la Pitié-Salpêtrière, APHP, Paris, France;
,
Sophie Bernardb Service d’Onco-Hématologie, Hôpital Saint-Louis, APHP, Paris, France;
,
Pauline Briceb Service d’Onco-Hématologie, Hôpital Saint-Louis, APHP, Paris, France;
,
Dimitri Psimarase OncoNeuroTox group: Center for investigations of patients with neurological complications after cancer treatment, Hôpitaux universitaires Pitié-Salpêtrière-Charles Foix et Val-de-Grâce, Paris, France
&
Timothée Lengleta Département de Neurophysiologie, Hôpital de la Pitié-Salpêtrière, APHP, Paris, France; ;e OncoNeuroTox group: Center for investigations of patients with neurological complications after cancer treatment, Hôpitaux universitaires Pitié-Salpêtrière-Charles Foix et Val-de-Grâce, Paris, France
 show all
Pages 547-549 | Received 16 Mar 2018, Accepted 30 May 2018, Published online: 22 Jul 2018

References

  • Okazaki T, Honjo T. PD-1 and PD-1 ligands: from discovery to clinical application. Int Immunol. 2007;19:813–824.
  • Patnaik A, Kang SP, Rasco D, et al. Phase I study of pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in patients with advanced solid tumors. Clin Cancer Res. 2015;21:4286–4293.
  • Chen R, Zinzani PL, Fanale MA, et al, for the KEYNOTE-087. Phase II study of the efficacy and safety of pembrolizumab for relapsed/refractory classic Hodgkin lymphoma. J Clin Oncol. 2017;35:2125–2132
  • Zimmer L, Goldinger SM, Hofmann L, et al. Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy. Eur J Cancer. 2016;60:210–225.
  • Touat M, Talmasov D, Ricard D, et al. Neurological toxicities associated with immune checkpoint inhibitors. Curr Opin Neurol. 2017;30:659–668.
  • Hughes RA, Britton T, Richards M. Effects of lymphoma on the peripheral nervous system. J R Soc Med. 1994;87:526–530.
  • Lorenzoni PJ, Scola RH, Carsten AL, et al. Chronic inflammatory demyelinating polyradiculoneuropathy in chronic graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: case report. Arq Neuropsiquiatr. 2007;65:700–704.
  • Kelly JJ, Karcher DS. Lymphoma and peripheral neuropathy: a clinical review. Muscle Nerve. 2005;31:301–313.
  • Viala K, Béhin A, Maisonobe T, et al. Neuropathy in lymphoma: a relationship between the pattern of neuropathy, type of lymphoma and prognosis? J Neurol Neurosurg Psychiatry. 2008;79:778–782.
  • Anderson D, Beecher G, Steve TA, et al. Neurological nuance: Hodgkin lymphoma presenting with Guillain-Barré syndrome. Muscle Nerve. 2017; 55:601–604.
  • Oh BC, Lim Y-M, Kwon YM, et al. A case of Hodgkin’s lymphoma associated with sensory neuropathy. J Korean Med Sci. 2004;19:130–133.
  • De Maleissye MF, Nicolas G, Saiag P. Pembrolizumab-induced demyelinating polyradiculoneuropathy. N Engl J Med. 2016;375:296–297.
  • Aya F, Ruiz-Esquide V, Viladot M, et al. Vasculitic neuropathy induced by pembrolizumab. Ann Oncol. 2017;28:433–434.
  • Kao JC, Liao B, Markovic SN, et al. Neurological complications associated with anti-programmed death 1 (PD-1) antibodies. JAMA Neurol. 2017;74:1216–1222.
  • Herbaux C, Gauthier J, Brice P, et al. Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma. Blood. 2017;129:2471–2478.
  • Kumar V, Chaudhary N, Garg M, et al. Current diagnosis and management of immune related Adverse Events (irAEs) induced by immune checkpoint inhibitor therapy. Front Pharmacol. 2017;8:49.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.